Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Seralogix is a systems biology and bioinformatics company that provides advanced computational solutions for the analysis of complex biological data. The company specializes in integrating multi-omics data, including transcriptomics, proteomics, and metabolomics, to reconstruct dynamic biological pathways and identify key regulatory mechanisms. Their proprietary BIO-SIGNET platform enables researchers to model cellular responses to drugs, toxins, and pathogens, facilitating drug discovery and biomarker identification. Seralogix serves a diverse clientele across academia, government, and the pharmaceutical industry, offering both software tools and expert consulting services.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Seralogix.